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Dr Mark Conrad (Boston, Mass). I would like to commend
the authors on attempting to answer a very difficult question that
we all face, and thank you for allowingme to review themanuscript
ahead of time. The authors reviewed 85 patients with diabetes who
underwent lower extremity revascularization for critical limb isch-
emia and compared the revascularization methods, endovascular
therapy (ENDO) vs open bypass surgery (OPEN), for early hemo-
dynamic outcomes as determined by changes in ankle brachial
index (ABI) and toe pressures. They concluded that appropriate
patient selection will lead to hemodynamic improvement in pa-
tients regardless of whether they have open or endovascular ther-
apy.
I have several questions. First, one of the issues that we run
into with patients with diabetes is that many have noncompressible
vessels. How many of your patients were excluded from this study
because their ABI was unattainable due to noncompressible ves-
sels?
Second, what is the role of duplex surveillance in these pa-
tients, and would it have been a better method for identifying early
hemodynamic compromise, especially in patients in whom an ABI
could not be established?
With regard to patient selection, how do you decide who
undergoes bypass at your institution?Were the bypasses performed
on patients who failed endovascular therapy first, and were the
ENDO patients those who were poor surgical candidates with
compromised conduits?
What was your rationale, including the 10% aortoiliac lesions?
As we know, aortobifemoral bypasses and iliac stents have a differ-
ent expected long-term outcome than patients who undergo in-
frainguinal interventions. Did all of the patients show ABI im-
provements? Were there any failures of treatment?
Finally, the majority of your patients were treated for ulcers.
Was there a difference in the time to ulcer healing between the two
modalities?
I enjoyed your article.
Dr Luke X. Zhan. Thank you very much, Dr Conrad, for
your generous time in reviewing this manuscript.
You have raised some very important and interesting ques-
tions.
i
iRegarding how many patients were excluded from our studies
ue to incompressible vessels, when we compiled the database for
atients who underwent interventions, there were over 300 pa-
ients whomet the criteria for diabetes and critical limb ischemia. A
ot of them either did not have hemodynamic data due to medial
alcinosis or the presence of ulcer that precluded them from such a
easurement. At the end, we included a total of 85 patients from
he initial 300 patients.
Duplex scans had not been used in this study. ABI and toe
ressures are more established benchmarks and, in our experience,
BI and toe pressures are also more reproducible than measure-
ent from duplex scans. It is an interesting idea that perhaps we
an obtain hemodynamic data from duplex scans on patients on
hom ABI and toe pressures cannot be meaningfully measured.
The third question regarding the decision for who undergoes
NDO vs OPEN bypass and whether there is any crossover. There
re very few patients who crossed over from ENDO due to failure
f OPEN bypass. The decision for OPEN vs ENDO is largely
ased on standard criteria and individual patient characteristics. In
ur institute, typically TASC D lesions were selected for open
ypass surgery. Decision is also made based on the availability of
unoff vessels, the life expectancy of a patient, the comorbidities,
nd the clinical presentation of a patient. Certain patients were
elected to undergo ENDO because of being poor surgical candi-
ates. So, indeed, we can argue about the selection bias as to which
opulation of patients got surgery and which population got
NDO therapy, but I think there can be bias either way.
DrConrad. I wanted to knowwhy you included the aortoiliac
atients instead of just doing infrainguinal and the time to heal
lcers, whether there was a difference between the two groups.
Dr Zhan. These are very important questions. We included
hem because the patients with diabetes tend to have multiple
evels of lesions, and often we will treat the inflow first. In our
xperience, by improving the inflow, sometimes it generates
nough hemodynamic response to push the patient over the hump
nd heal the foot or leg ulcer. The time to healing is a very
mportant question for the long-term clinic response. In this study,
e focused primarily on immediate response. We are certainly
nterested in following long-term outcomes, including ulcer heal-
ng. Hopefully, we will have some data to discuss in the future.
